DXCM
DexCom, Inc.
NMS
$73.45
-1.42
(-1.90%)
Blow-off · +2.03σ
Hot zone
Grade B
Valuation
Market cap
$28.3B
P/E (ttm)
31.5
Forward P/E
23.9
Beta (5y)
1.40
Shares out
385.9M
Div yield
—
Profitability & returns
ROE
35.6%
Net margin
19.3%
FCF margin
21.9%
Debt / equity
0.47
Trading information
Last price
$73.45
Day range
$73.45 – $73.45
52-wk range
$56.72 – $76.35
Avg volume
5.3M
RSI (2)
44.1
TAO zone
Blow-off
Company
Sector
Healthcare
Industry
Medical Devices
Exchange
NMS
Next earnings
2026-07-29
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for…